Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2716 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

ViroPharma acquires Lev Pharmaceuticals

Lev stockholders will receive $2.25 in cash, 0.042146 shares of ViroPharma common stock and one non- transferable contingent value right which entitles the holder to receive up to

Schering-Plough Q3 sales up

The company has reported net income of $589 million for the third quarter of 2008, compared to $750 million posted in the third quarter of 2007. Diluted earnings

Pfizer reports surge in Q3 net income

Pfizer has reported revenues of $12 billion for the third quarter of 2008, consistent with the year-ago quarter, despite the negative impact of the loss of US exclusivity